PMA device
OrganOx metra® System
Organox Limited · Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK, Class III) · First FDA decision Dec 9, 2021, newest Oct 9, 2026Liver disease and liver cancer
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
16
PMA pathway
Device trials
10
Naming "OrganOx metra"
MAUDE reports
546
Brand "OrganOx metra", since 2015
PubMed studies
22
Mentioning "OrganOx metra"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing OrganOx metra® System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 16 decisions filed under this name.
- OrganOx metra® SystemPMA supplement
P200035-S038 · Decided Oct 9, 2026 · 168 days after receipt · Normal 180 Day Track
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
- OrganOx metra® SystemPMA supplement
P200035-S035 · Decided Mar 30, 2026 · 89 days after receipt · Normal 180 Day Track
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
- OrganOx metra® SystemPMA supplement
P200035-S033 · Decided May 21, 2026 · 142 days after receipt · Normal 180 Day Track No User Fee
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P200035-S014, P200035-S012, P200035-S011, P200035-S008, P200035-S007, P200035-S006, P200035-S003, P200035-S002, P200035-S001, P200035
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Liver Transplantation for MalignanciesNational analysisReview closedCAG-00091RUpdated Sep 18, 2026
- Liver Transplantation for Malignancies other than Hepatocellular CarcinomaNational analysisReview closedCAG-00101NUpdated Sep 15, 2026
- Liver Transplantation for MalignanciesNational analysisReview closedCAG-00091NUpdated Sep 15, 2026
- Liver TransplantationNational analysisReview closedCAG-00053NUpdated Sep 15, 2026
- Adult Liver TransplantationNational determinationOn the books260.1Updated Aug 17, 2026
- Dental Examination Prior to Kidney TransplantationNational determinationOn the books260.6Updated Jun 15, 2020
- Nonselective (Random) Transfusions and Living Related Donor Specific Transfusions (DST) in Kidney TransplantationNational determinationOn the books110.16Updated Jun 12, 2020
- Pediatric Liver TransplantationNational determinationOn the books260.2Updated Apr 20, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "OrganOx metra", any status and sponsor, newest update first.
- RESTORE Declined Livers StudyCompleted
Washington University School of MedicineAcademic, hospital or other
NCT04483102 · 24 participants · Start Dec 3, 2020 · Primary completion May 14, 2025
Device: Declined liver in Normothermic Machine Perfusion (NMP) · For: Liver Diseases; Surgery; Transplant; Failure, Liver
Sites: St Louis, Missouri
- RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver FailureNot yet recruiting
eGenesis, INCNot on our public-company list
NCT07429838 · 20 participants (planned) · Start Oct 2026 · Primary completion Dec 2027
Device: metra® Extracorporeal Liver Cross-Circulation (ELC) system (OrganOx) · For: Acute on Chronic Liver Failure (ACLF); Hepatic Encephalopathy (HE)
Sites: St Louis, Missouri; Madison, Wisconsin
- Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting TimePivotal-lookingRecruiting
Charite University, Berlin, GermanyAcademic, hospital or other
NCT06874296 · 186 participants (planned) · Start Jun 2, 2025 · Primary completion May 31, 2029
Device: Quality Assessment with Normothermic Machine Perfusion (NMP) · For: Liver Transplantation; Liver Diseases; Surgery
Sites: Hamburg, Germany; Aachen, Germany; Bonn, Germany · 10 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "OrganOx metra", and for the whole product code for context.
This brand
546 reports: 406 malfunction, 135 injury, 3 death
Whole product code QQK
566 reports: 426 malfunction, 135 injury, 3 death
Newest reports for this brand
- OrganOx MetraMalfunction
3011560054-2026-00238 · Received Oct 28, 2026 · Event dated Oct 4, 2026
Device type: Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)
Device problem as coded: Loose or Intermittent Connection
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- OrganOx MetraMalfunction
3011560054-2026-00234 · Received Oct 28, 2026 · Event dated Oct 3, 2026
Device type: Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)
Device problem as coded: Loose or Intermittent Connection; Temperature Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- OrganOx MetraMalfunction
3011560054-2026-00237 · Received Oct 28, 2026 · Event dated Oct 4, 2026
Device type: Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)
Device problem as coded: Pressure Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0501-2025 · Started Oct 15, 2024 · Posted by FDA Nov 21, 2024
Reason given: Battery movement led to damage of one of the battery cells causing it to short to the battery retention bracket
Cause as FDA categorized it: Device Design · Device type: Normothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation (QQK)
Published research
The most relevant PubMed records for "OrganOx metra"[tiab]. The summary above synthesizes these.
- Assessment and Transplantation of Orphan Donor Livers: A Back-to-Base Approach to Normothermic Machine Perfusion.
Reiling J, Butler N, Simpson A, et al. · Liver Transpl · 2020Research Support, Non-U.S. Gov't
- Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation.
Olumba FC, Zhou F, Park Y, et al. · J Am Coll Surg · 2023Research Support, Non-U.S. Gov't
- Mitochondrial respiration during normothermic liver machine perfusion predicts clinical outcome.
Meszaros AT, Hofmann J, Buch ML, et al. · EBioMedicine · 2022Clinical Trial
- Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers.
Weissenbacher A, Bogensperger C, Oberhuber R, et al. · Transplantation · 2022Research Support, Non-U.S. Gov't
- Predictive value of early postoperative lactate (<6ߕh) during normothermic machine perfusion and outcome after liver transplantation: results from a multicentre study.
Hofmann J, Meszaros AT, Butler A, et al. · Br J Surg · 2024Multicenter Study
- Enhancing Organ Availability: Increased DCD Liver Utilization Following Implementation of a Normothermic Machine Perfusion Program.
Idrees MT, Land G, Kathuria N, et al. · ANZ J Surg · 2025
- Current review of machine perfusion in liver transplantation from the Japanese perspective.
Harada N, Yoshizumi T, Mori M · Surg Today · 2022Review
- Simultaneous quantification of native human and transgenic porcine liver function in a decedent model of extracorporeal cross-circulation.
Shaked A, McRae MP, Imperial JC, et al. · Am J Transplant · 2026
- Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multicenter, Real-World Risk-Matched Analysis.
Wehrle CJ, Zhang M, Khalil M, et al. · Ann Surg · 2024Multicenter Study, Research Support, Non-U.S. Gov't
- Methaemoglobinaemia Can Complicate Normothermic Machine Perfusion of Human Livers.
Tingle SJ, Ibrahim I, Thompson ER, et al. · Front Surg · 2021
- Dual Lactate Clearance in the Viability Assessment of Livers Donated After Circulatory Death With Ex Situ Normothermic Machine Perfusion.
Xu M, Zhou F, Ahmed O, et al. · Transplant Direct · 2021
- A New Era of Decision-making in Liver Transplantation: A Prospective Validation and Cost-effectiveness Analysis of FMN-guided Liver Viability Assessment During Normothermic Machine Perfusion.
Wehrle CJ, Satish S, Dewey E, et al. · Ann Surg · 2025Validation Study, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code QQK.
- Organ Care System (OCS) LiverTransMedics, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.